NEW YORK (Reuters Health) – Drug-eluting stents (DES) seem to be safer and more effective than bare-metal stents in saphenous vein grafts (SVG), according to a systematic review…
NEW YORK (Reuters Health) – In a pilot study of patients undergoing on-pump coronary artery bypass grafting (CABG), adding clopidogrel to aspirin did not reduce overall graft occlusion,…
NEW YORK (Reuters Health) – Acute hyperglycemia, even without diabetes, raises the risk of contrast-induced nephropathy and death in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary…
NEW YORK (Reuters Health) – The combination of aspirin and clopidogrel is no better than aspirin alone for preventing saphenous vein graft (SVG) intimal hyperplasia after coronary artery…
NEW YORK (Reuters Health) – In a prospective study, the beta-1 selective blocker bisoprolol proved more effective than the non-selective beta-blocker carvedilol in preventing atrial fibrillation after coronary…
NEW YORK (Reuters Health) – Smoking does not affect outcomes after early clopidogrel use in patients with acute coronary syndrome (ACS), according to findings published in the November…
NEW YORK (Reuters Health) – Hydroxychloroquine may reduce the heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Use of hydroxychloroquine to treat rheumatoid arthritis is associated…
NEW YORK (Reuters Health) – The management of heart failure guided by an individualized target level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) doesn’t lead to clinically significant improvements…
NEW YORK (Reuters Health) – The mineralocorticoid receptor blocker eplerenone has advantages over spironolactone in the treatment of chronic heart failure (CHF), a Japanese team reports. In particular,…
NEW YORK (Reuters Health) – Contrary to growing concerns, the incidence of coronary artery aneurysms after implantation of drug-eluting stents is low, and when an aneurysm does occur…